Successful management of profound thrombocytopenia after lung and heart-lung transplantation.
Malouf
M A
MA
Heart and Lung Transplant Unit, St Vincent's Hospital, Darlinghurst, Sydney, Australia. mmalouf@stvincents.com.au
Milliken
S
S
Glanville
A R
AR
D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D016041:Heart-Lung Transplantation / Q000009:adverse effects*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000188:drug therapy* / Q000209:etiology
D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents